Beijing Jingdu Children's Hospital
China’s Top Private Pediatric Hematology & Oncology Hospital | Official Pediatric CAR-T Center
Hospital Overview
Beijing Jingdu Children’s Hospital is China’s leading private pediatric hematology-oncology facility, exclusively dedicated to children and adolescents (0–18 years). It is one of the few hospitals in China officially authorized to administer commercial CAR-T cell therapy to pediatric patients and has extensive experience in high-risk leukemia, lymphoma, neuroblastoma, and bone marrow transplantation.
Special Features
- 100% pediatric-focused environment with child-friendly facilities
- Official pediatric administration center for Yescarta & Carteyva CAR-T
- One of the highest pediatric CAR-T volumes worldwide
- Multidisciplinary international team (US/Europe trained doctors)
Accreditations & Partnerships
- Authorized by NMPA for pediatric CAR-T therapy
- Cooperation with St. Jude Children’s Research Hospital (USA)
- Member of Chinese Pediatric Oncology Group
Pediatric CAR-T & Advanced Therapies
CAR-T Therapy for Children
- Approved for relapsed/refractory B-ALL and B-cell lymphoma in children
- Both Yescarta and Carteyva available with NRDL reimbursement
- Excellent safety management for CRS/ICANS in pediatric patients
Bone Marrow Transplantation
- Large haploidentical & matched unrelated donor program
- High survival rates for high-risk leukemia
- Specialized reduced-intensity conditioning for children
Other Advanced Treatments
- Blincyto (blinatumomab) & Inotuzumab for ALL
- Tumor vaccines & NK cell therapy trials
- Precision medicine with NGS for every patient
Available Advanced Treatments
| Treatment | Availability |
|---|---|
| Pediatric CAR-T Therapy | ✓ (Yescarta & Carteyva) |
| Bone Marrow Transplantation | ✓ (High Volume) |
| Blincyto / Inotuzumab | ✓ |
| Immunotherapy & Targeted Therapy | ✓ |
| Clinical Trials (TIL/NK) | ✓ |
Why International Families Choose Jingdu
Clinical Excellence
- Survival rates comparable to top US/European pediatric centers
- Specialized in the most complex and relapsed cases
- 24/7 pediatric intensive care
Cost Advantage
- Pediatric CAR-T total cost: ~$50,000–80,000 USD (after reimbursement)
- 70–90% lower than USA/Europe
Family-Centered Services
- Arabic, Russian, English, French medical interpreters
- Family accommodation inside hospital
- Visa assistance, school support for siblings
Contact & Location
Address
No. 2 Jingyuan North Street
Beijing Economic-Technological Development Area
Daxing District, Beijing 100176, China
International Patients
Phone: +86-010-80728888
WhatsApp: +86 186 1174 1613
Email: international@jingduchildrens.com
Available in Other Languages
Ready for Pediatric Cancer Treatment at Jingdu Beijing?
Get free specialist evaluation and personalized treatment plan for your child from China’s top pediatric oncology team.
Request Free Consultation